Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Michigan Cardiovascular Institute (MCVI) is a leading cardiovascular medical practice and clinical research center based in Saginaw, Michigan. The institute provides a comprehensive range of heart and vascular services, including interventional cardiology, electrophysiology, and peripheral vascular disease management. MCVI is particularly distinguished by its robust clinical research department, which has participated in over 400 clinical trials for pharmaceutical and medical device innovations. Now part of the Ascension Michigan health system, MCVI continues to serve as a regional hub for advanced cardiac care and clinical investigation. The institute is frequently selected as a high-enrolling site for global Phase 2 and Phase 3 trials, contributing significantly to the development of new cardiovascular therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Michigan Cardiovascular Institute.